MedTrace Logo

Scarring At Donor Sites After Split-Thickness Skin Graft.

NCT04490213 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2020-07-29

No results posted yet for this study

Summary

The aim of this study was to investigate if previous findings on the association between dressing treatments and subjective opinion on final donor site scar outcome using the patient scale of POSAS could be confirmed objectively.

Scar outcome measurements were assessed by a blinded observer using POSAS and the device: Cutometer dual MPA 580 (Courage and Khazaka Electronic GmbH, Cologne, Germany) to measure the viscoelasticity of the skin.

Conditions

  • Donor Site Complication

Interventions

OTHER

Allevyn, Aquacel and Tegaderm, Mediskin

Wound dressing tested earlier on donor sites, in this study scar outcome between the 3 dressing groups are compared.

Sponsors & Collaborators

  • University Hospital, Linkoeping

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-15
Primary Completion
2019-03-01
Completion
2019-03-01

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04490213 on ClinicalTrials.gov